Skip to main content

Company

Lilly

39 published works

  1. Budding Trends

    Trip Advisor: FDA Publishes Guidance on Psychedelic Drug Trials

    By Slates C. Veazey, Hillary Campbell

    We've been waiting on this one for three years. If you've frequented this blog, you know three years is basically an eternity in Food and Drug Administration (FDA) years but…

  2. In-House Ops

    Goodwin’s Life Sciences Deal Flow Points to a More Selective M&A Market

    By Corporate Counsel Business Journal

    Life sciences M&A is back, but not as a free-for-all.Goodwin positions itself around a clear 2026 market signal: Life sciences M&A has reemerged as a competitive arena after a quieter…

  3. Your ERISA Watch

    Your ERISA Watch – Week of November 19, 2025

    By Peter Sessions

    This week we are reporting on twice as many cases as last week, which sounds like a lot! Unfortunately, there were only three cases in last week’s edition, so suddenly…

  4. Roberts Disability Law Blog

    District Court Upholds Denial of Severance Benefits Based on Expense Report “Misconduct”

    By Michelle Roberts

    In Cella v. Lilly Usa LLC & The Lilly Severance Pay Plan, No. 1:24-CV-00814-TWP-MKK, 2025 WL 3134607 (S.D. Ind. Nov. 10, 2025), the U.S. District Court for the Southern District…

  5. Nonprofit Law Prof Blog

    2023 Global Philanthropy Tracker Reports $70 Billion in 2020 Cross-Border Philanthropy

    By nonprofitlawprof

    The Lilly Family School of Philanthropy at IUPUI has published the 2023 Global Philanthropy Tracker. Its key findings include:In 2020, 47 countries representing 61 percent of the global population and…

  6. Nonprofit Law Prof Blog

    April 8th: Charitable Crowdfunding: Who Give, to What, and Why? (Lilly Family School of Philanthropy)

    By nonprofitlawprof

    I am very much looking forward to participating in a presentation with Amy Sample Ward and Una Osili on new research from the Lilly Family School of Philanthropy about charitable…

  7. Nonprofit Law Prof Blog

    Strong Fundraising Years Ahead Despite Pandemic

    By nonprofitlawprof

    As reported in The Chronicle of Philanthropy, the Lilly Family School of Philanthropy recent report predicts a period of “broad philanthropic growth” is forthcoming the next two years as the…

  8. Big Molecule Watch

    FDA Approves LYUMJEV (insulin lispro-aabc injection)

    By Big Molecule Watch

    This week, the FDA approved LYUMJEV (insulin lispro-aabc), a new insulin lispro product by Lilly. LYUMJEV is a formulation of insulin lispro, developed to speed the absorption of insulin into…

  9. Big Molecule Watch

    COVID-19 Pandemic May Impact Biosimilars

    By Big Molecule Watch

    The COVID-19 pandemic has introduced new challenges for the pharmaceutical industry, including makers of biosimilars.  In response, the FDA has asked pharmaceutical makers to closely monitor their supply chains and…

  10. Life Sciences Legal Insights

    Biotech & Life Sciences Trends to Consider Following JPM 2020: M&A, Venture Capital and More

    By Michael T. Esquivel

    The annual gathering of life sciences executives and investors in San Francisco that many now call “JPM Week” recently concluded, marking the J.P. Morgan Healthcare Conference’s 38th year. The Big…